Skip to main content
DBCCF
OTC Life Sciences

Decibel Cannabis Reports 22% Revenue Growth to $113M in 2025, Projects Strong 2026

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$0.087
Mkt Cap
$50.075M
52W Low
$0.034
52W High
$0.109
Market data snapshot near publication time

summarizeSummary

Decibel Cannabis Company reported strong full-year 2025 financial results, with net revenue growing 22% to $113 million, Adjusted EBITDA increasing 29% to $23 million, and Free Cash Flow surging 292% to $5.5 million. International sales were a significant highlight, growing 484% to $24 million. The company also provided positive 2026 guidance, projecting net revenue of $130-$135 million and Adjusted EBITDA of $27-$31 million, indicating continued robust growth. This strong performance, coupled with the successful integration of the AgMedica acquisition which exceeded its EBITDA target, suggests a positive trajectory for the company. Traders will be watching for continued international expansion and the impact of new domestic product launches on market share.

At the time of this announcement, DBCCF was trading at $0.09 on OTC in the Life Sciences sector, with a market capitalization of approximately $50.1M. The 52-week trading range was $0.03 to $0.11. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed DBCCF - Latest Insights

DBCCF
Apr 16, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8